Larvol Delta - Biond-Biologics-Announces-Oral-Presentation-for-BND67-an-Inhibitor-of-CD28-Shedding-a-Potential-Novel-Resistance-Mechanism-to-Anti-PD1-Therapy-at-the-American-Association-for-Cancer-Research-AACR-2022-Annual-Meeting

BND-67 - Biond Biologics

BND-35 - Biond Biologics

https://www.prnewswire.com/news-releases/biond-biologics-announces-oral-presentation-for-bnd-67-an-inhibitor-of-cd28-shedding-a-potential-novel-resistance-mechanism-to-anti-pd-1-therapy-at-the-american-association-for-cancer-research-aacr-2022-annual-meeting-301506466.html

Mar 21, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next